Access

Letters to Nature

Nature 401, 493-497 (30 September 1999) | doi:10.1038/46816; Received 22 April 1999; Accepted 28 July 1999

Open Innovation Challenges

naturejobs

Cytochrome P450 2C is an EDHF synthase in coronary arteries

Beate Fisslthaler1, Rüdiger Popp1, Ladislau Kiss2, Michael Potente1, David R. Harder3, Ingrid Fleming1 & Rudi Busse1

  1. Institut für Kardiovaskuläre Physiologie, Klinikum der J. W. Goethe-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany
  2. Zentrum der Inneren Medizin, Justus Liebig Universität Gies zligen, Klinikstrasse 36, D-35392 Gies zligen, Germany
  3. Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA

Correspondence to: Ingrid Fleming1 Correspondence and requests for material should be addressed to I.F. (e-mail: Email: fleming@em.uni-frankfurt.de).

Top

In most arterial beds a significant endothelium-dependent dilation to various stimuli persists even after inhibition of nitric oxide synthase and cyclo-oxygenase. This dilator response is preceded by an endothelium-dependent hyperpolarization of vascular smooth muscle cells, which is sensitive to a combination of the calcium-dependent potassium-channel inhibitors charybdotoxin and apamin, and is assumed to be mediated by an unidentified endothelium-derived hyperpolarizing factor (EDHF)1, 2. Here we show that the induction of cytochrome P450 (CYP) 2C8/34 in native porcine coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as EDHF-mediated hyperpolarization and relaxation. Transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides results in decreased levels of CYP 2C and attenuates EDHF-mediated vascular responses. Thus, a CYP-epoxygenase product is an essential component of EDHF-mediated relaxation in the porcine coronary artery, and CYP 2C8/34 fulfils the criteria for the coronary EDHF synthase.